Maze Therapeutics, Inc.
MAZE
$41.49
$4.2211.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.55% | -124.22% | -0.90% | -11.30% | -0.02% |
| Total Depreciation and Amortization | -27.54% | -24.00% | -28.00% | -27.77% | -21.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -27.01% | 48.25% | -48.96% | -25.19% | 113.35% |
| Change in Net Operating Assets | 109.58% | -142.73% | -672.29% | 145.86% | -643.30% |
| Cash from Operations | -6.19% | -120.72% | -25.94% | -8.76% | -16.19% |
| Capital Expenditure | 33.98% | -145.63% | -7.17% | -1,679.41% | -3,533.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -64,834.95% | -145.63% | -7.17% | -1,679.41% | -3,533.33% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 63,509.29% | 674.68% | 34,935.07% | 425.00% | 2,725.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | 6,786.37% | 297.40% | 418.20% | 334.04% | -26,975.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 305.17% | -120.57% | 11,178.96% | 1,151.57% | -27.54% |